ARCHIVES

House Committee Investigates Marketing Practices Of Amgen And J&J For ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 13 | April 4, 2008

Download PDF Visit The Full Archive

Related Articles

Large Pregnancy Weight Gain Raises Risk For Breast Cancer

May 31, 2002

Cancer Program Advocates, Success Overcame Powerful Negative Factors To Win Budget Fight

August 10, 1979

As NCI Sets Deadline For B-06 Reanalysis, Fisher Lawyer Says Demand Is Illegal

February 3, 1995

Congressman Requests GAO Inquiry into FDA Foreign Inspections

April 19, 1996

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

Medenica Patients Drop Suit Against Doctors; Hospital To Be sold

August 19, 1994